UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Status of research and development of pediatric vaccines for Streptococcus pneumoniae

Vaccine, 2016-06, Vol.34 (26), p.2959-2961

Alderson, Mark R

2016

Volltextzugriff (PDF)

Meningococcal Vaccine in Mali and Gambia. Reply

The New England journal of medicine, 2023-08, Vol.389 (6), p.577-578

2023

Volltextzugriff (PDF)

WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016

Vaccine, 2019-11, Vol.37 (50), p.7307-7314

2019

Volltextzugriff (PDF)

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study

The Lancet infectious diseases, 2018-10, Vol.18 (10), p.1088-1096

2018

Volltextzugriff (PDF)

Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics

Vaccine, 2019-11, Vol.37 (50), p.7391-7393

2019

Volltextzugriff (PDF)

A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults

The Pediatric infectious disease journal, 2020-04, Vol.39 (4), p.345-351

2020

Volltextzugriff (PDF)

Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines

The Journal of infectious diseases, 2019-10, Vol.220 (220 Suppl 4), p.S274-S278

2019

Volltextzugriff (PDF)

Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial

The Lancet infectious diseases, 2021-06, Vol.21 (6), p.834-846

2021

Volltextzugriff (PDF)

Development strategy and lessons learned for a 10-valent pneumococcal conjugate vaccine (PNEUMOSIL®)

Human vaccines & immunotherapeutics, 2021-08, Vol.17 (8), p.2670-2677

2021

Volltextzugriff (PDF)

Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia

The New England journal of medicine, 2023-05, Vol.388 (21), p.1942-1955

2023

Volltextzugriff (PDF)

Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review

The Journal of infection, 2022-03, Vol.84 (3), p.289-296

2022

Volltextzugriff (PDF)

Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial

The Lancet infectious diseases, 2023-05, Vol.23 (5), p.609-620

2023

Volltextzugriff (PDF)

Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia—Results of a phase 1/2 randomized, double-blinded, controlled trial

Vaccine, 2020-01, Vol.38 (2), p.399-410

2020

Volltextzugriff (PDF)

Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers

The New England journal of medicine, 2021-06, Vol.384 (22), p.2115-2123

2021

Volltextzugriff (PDF)

Panproteome-wide analysis of antibody responses to whole cell pneumococcal vaccination

eLife, 2018-12, Vol.7

2018

Volltextzugriff (PDF)

Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys

Proceedings of the National Academy of Sciences - PNAS, 2009-02, Vol.106 (7), p.2301-2306

2009

Volltextzugriff (PDF)

Broadly Protective Protein-Based Pneumococcal Vaccine Composed of Pneumolysin Toxoid—CbpA Peptide Recombinant Fusion Protein

The Journal of infectious diseases, 2014-04, Vol.209 (7), p.1116-1125

2014

Volltextzugriff (PDF)

Differential Immune Responses and Protective Efficacy Induced by Components of a Tuberculosis Polyprotein Vaccine, Mtb72F, Delivered as Naked DNA or Recombinant Protein

The Journal of immunology (1950), 2004-06, Vol.172 (12), p.7618-7628

2004

Volltextzugriff (PDF)

Vaccines to Prevent Meningitis: Historical Perspectives and Future Directions

Microorganisms (Basel), 2021-04, Vol.9 (4), p.771

2021

Volltextzugriff (PDF)

Panel 6: Vaccines

Otolaryngology-head and neck surgery, 2017-04, Vol.156 (4_suppl), p.S76-S87

2017

Volltextzugriff (PDF)

Panel 8: Vaccines and immunology

International journal of pediatric otorhinolaryngology, 2020-03, Vol.130 (Suppl 1), p.109839-109839, Article 109839

2020

Volltextzugriff (PDF)

The Protective Effect of the Mycobacterium bovis BCG Vaccine Is Increased by Coadministration with the Mycobacterium tuberculosis 72-Kilodalton Fusion Polyprotein Mtb72F in M. tuberculosis-Infected Guinea Pigs

Infection and Immunity, 2004-11, Vol.72 (11), p.6622-6632

2004

Volltextzugriff (PDF)

Evaluation of Critical Quality Attributes of a Pentavalent (A, C, Y, W, X) Meningococcal Conjugate Vaccine for Global Use

Pathogens (Basel), 2021-07, Vol.10 (8), p.928

2021

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(205)
Mit Volltextzugriff
(200)

Publikationsform

Sprache

Englisch
(234)

Erscheinungsjahr

n.n

Thema

Science & Technology
(163)
Life Sciences & Biomedicine
(153)
Humans
(122)
Immunology
(71)
Animals
(60)
Biological And Medical Sciences
(55)
Female
(51)
Male
(47)
Mice
(36)
Fundamental And Applied Biological Sciences. Psychology
(33)
Vaccines
(30)
Adult
(29)
Medical Sciences
(26)
Infectious Diseases
(23)
Medicine, Research & Experimental
(23)
Microbiology
(23)
Research & Experimental Medicine
(23)
Amino Acid Sequence
(22)
Middle Aged
(22)
Molecular Sequence Data
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Status of research and development of pediatric vaccines for Streptococcus pneumoniae

Meningococcal Vaccine in Mali and Gambia. Reply

WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study

Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics

A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults

Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines

Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial

Development strategy and lessons learned for a 10-valent pneumococcal conjugate vaccine (PNEUMOSIL®)

Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia

Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review

Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial

Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia—Results of a phase 1/2 randomized, double-blinded, controlled trial

Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers

Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study

Panproteome-wide analysis of antibody responses to whole cell pneumococcal vaccination

Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys

Broadly Protective Protein-Based Pneumococcal Vaccine Composed of Pneumolysin Toxoid—CbpA Peptide Recombinant Fusion Protein

Differential Immune Responses and Protective Efficacy Induced by Components of a Tuberculosis Polyprotein Vaccine, Mtb72F, Delivered as Naked DNA or Recombinant Protein

Vaccines to Prevent Meningitis: Historical Perspectives and Future Directions

Panel 6: Vaccines

Panel 8: Vaccines and immunology

The Protective Effect of the Mycobacterium bovis BCG Vaccine Is Increased by Coadministration with the Mycobacterium tuberculosis 72-Kilodalton Fusion Polyprotein Mtb72F in M. tuberculosis-Infected Guinea Pigs

Evaluation of Critical Quality Attributes of a Pentavalent (A, C, Y, W, X) Meningococcal Conjugate Vaccine for Global Use

The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1

Suchergebnisse filtern